Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 9/20 | 0.35 |
| ▸ | GRM4 | Q14833 | 8/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25002664 | 0.81 | DYRK1A (0.33) | — | |
| SCHEMBL25002506 | 0.80 | PHGDH (0.33) | GRM4 | |
| SCHEMBL25003512 | 0.80 | PLCG1 (0.31) | — | |
| SCHEMBL25002464 | 0.79 | LMNA (0.30) | — | |
| SCHEMBL24896382 | 0.79 | GRM4 (0.35) | ACACBGRM4IRAK4 | |
| SCHEMBL24896464 | 0.79 | KDM4E (0.39) | ACACBGRM4 | |
| SCHEMBL25003332 | 0.79 | HASPIN (0.31) | — | |
| SCHEMBL25003585 | 0.79 | — | — | |
| SCHEMBL25003327 | 0.78 | SETD2 (0.34) | GRM4IRAK4 | |
| SCHEMBL30220512 | 0.77 | MAOA (0.38) | ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230039586-A1 | BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS | NIDO BIOSCIENCES, INC. | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230039586-A1 | BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS | AR, FSHR, NR5A1 | ACACB 522/4885GRM4 461/4885IRAK4 2754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.